News |
Investors
CONTACT US

Rafael Holdings

home Navigation
  • Leadership
    • Board of Directors
    • Executive Management
  • Leadership
    • Board of Directors
    • Executive Management
Investors

Investors

News

 
 
Sep 14, 2021
Click to open news item in new windowRafael Holdings Appoints Patrick Fabbio as Chief Financial Officer

Aug 24, 2021
Click to open news item in new windowRafael Holdings Announces Closing of $104.2 Million Private Placement

Aug 20, 2021
Click to open news item in new windowRafael Holdings Announces $104.2 Million Private Placement

Aug 17, 2021
Click to open news item in new windowRafael Holdings Expands Leadership Team with Three Highly Experienced Global Biopharmaceutical Executives to Build a Fully Integrated Cancer Metabolism Therapeutics Company

Jun 23, 2021
Click to open news item in new windowRafael Holdings and Rafael Pharmaceuticals Management Presented at the Raymond James 2021 Human Health Innovation Conference on June 22, 2021

Jun 21, 2021
Click to open news item in new windowRafael Holdings Announces Strategic Merger with Rafael Pharmaceuticals to Form a Focused Late-Stage Clinical Oncology Company

Jun 14, 2021
Click to open news item in new windowRafael Holdings Reports Third Quarter Fiscal Year 2021 Results

Jun 14, 2021
Click to open news item in new windowRafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors

May 28, 2021
Click to open news item in new windowRafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08

Apr 16, 2021
Click to open news item in new windowRafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08

 1   2   3     4    5   6   7   8 
 <<   <   >   >> 
  • Leadership
  • Press Releases
  • Investors
  • Contact Us
  • Privacy Policy
  • Disclaimer

Copyright © Rafael Holdings, Inc. All rights reserved


Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window